Pharma exec collapses near Trump at White House obesity-drug event

A man who was standing behind President Trump during an obesity-drug announcement in the Oval Office collapsed Thursday afternoon — prompting officials to cut the video feeds as officials rushed to help the man.

“Are you OK? Gordon, you OK?” asked Eli Lilly CEO David Ricks at the man began to collapse.

“Press out!” officials shouted as Trump rose from his seat at the Resolute Desk and Dr. Mehmet Oz rushed to provide assistance.

The Novo Nordisk exec collapsed in the Oval Office, but was revealed ot be okay. Reuters

Multiple news reports identified the man as Gordon Findlay, an executive at Novo Nordisk, which makes Ozempic, Rybelsus and Wegovy.

It was not immediately clear what medical issue caused the participant to collapse, though it is not uncommon for attendees to faint at White House events.

White House press secretary Karoline Leavitt said that a drug-company executive was “okay” after fainting behind President Trump Thursday in the Oval Office.

“During the Most Favored Nations Oval Office Announcement, a representative with one of the companies fainted,” Leavitt said.

“The White House Medical Unit quickly jumped into action, and the gentleman is okay. The Press Conference will resume shortly.”